Rebif

Active Ingredient(s): Interferon Beta-1a
FDA Approved: * March 7, 2002
Pharm Company: * SERONO INC
Category: Multiple Sclerosis

Interferon beta-1a (also interferon beta 1-alpha) is a cytokine in the interferon family used to treat multiple sclerosis (MS).[5] It is produced by mammalian cells, while interferon beta-1b is produced in modified E. coli.[6] Some research indicates that interferon injections may result in an 18–38% reduction in the rate of MS relapses.[7] Interferon beta has not been shown to slow the advance of disability.[8][9... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions

Dosage List

Rebif 22 ug/.5ml Subcutaneous Injection, Solution
NDC: 44087-0022
Labeler:
Emd Serono, Inc.
Rebif 44 ug/.5ml Subcutaneous Injection, Solution
NDC: 44087-0044
Labeler:
Emd Serono, Inc.
Rebif Subcutaneous Kit
NDC: 44087-8822
Labeler:
Emd Serono, Inc.

Related Brands

Drugs with the same active ingredients